If you travel to Japan, you should not eat this product… ‘Red yeast’ recovered after 26 people were hospitalized

by times news cr

2024-03-25 17:29:42

26 people hospitalized after ingesting Kobayashi Pharmaceutical red malt products… kidney problems
Pharmaceutical company supplies yeast as raw material to 52 companies… Companies recall one after another

ⓒNewsis

People who consumed ‘Red Koji (紅麹)’ released by a Japanese pharmaceutical company suffered kidney problems and were hospitalized, causing an uproar. Since there are 52 companies that used this yeast as a food ingredient, companies are recalling it one after another.

According to local public broadcasters NHK and Jiji News on the 25th, Kobayashi Pharmaceutical announced that 20 people who consumed health foods containing red koji ingredients were newly hospitalized.

Accordingly, the number of patients hospitalized after eating red yeast increased to 26, adding to 6 last week.

Red koji is made by propagating red koji bacteria, a type of grain such as rice, and has long been used as a food coloring agent.

In Japan, the ingredient ‘Rosuvastatin’ in red koji is known to have a cholesterol-lowering effect, and many health foods using red koji have been sold.

However, it is known that red yeast fungi contain a component that produces a mold poison called ‘citrinum’, which may cause kidney disease.

Previously, on the 22nd, Kobayashi Pharmaceutical announced that it would frequently recall functionally labeled foods using red malt. It was explained that this was because health damage such as kidney disease occurred among consumers who consumed it. They announced that they would be recalling 5 products, including ‘Red Koji Cholesterol Help 60 pills, 20-day supply’.

Kobayashi Pharmaceutical’s series of products, which claim to be effective in lowering cholesterol levels by using red koji, have annual sales of 600 million yen (about 5.3 billion won). The products subject to recall have been sold in drug stores and elsewhere in Japan since 2021, and the cumulative number of sales is nearly 1.1 million, the Nippon Keizai Shimbun (Nikkei) reported.

The problem is that Kobayashi Pharmaceutical also provided red yeast to other companies.

Kobayashi Pharmaceutical announced on the 24th that it had supplied red malt as a raw material to 52 companies for beverages and seasonings. It has been supplied as raw material since 2016.

Accordingly, product recall announcements by companies that supplied raw materials are continuing. Takara Shuzo, a liquor company, sells Japanese sake ‘Shojukmae Shiratakekura Mio Premium Rose’, and a Fukuoka-based mail order company sells ‘Concentrated Cheese Senbei, which helps lower LDL cholesterol’. announced that it would recall.

Additionally, Kumbun Foods announced that it would recall salted squid products. Mamefuku, a soybean confectionery specialty store in Nagoya, announced that it was recalling products such as “Shrimp Salt Almonds” that use red malt.

As Kobayashi Pharmaceutical has many companies that provided red yeast as a raw material, it is expected that the number of companies declaring a recall will increase.

[서울=뉴시스]

Hot news now

2024-03-25 17:29:42

You may also like

Leave a Comment